These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8655118)

  • 1. [Magnesium deficiency after kidney transplantation and cyclosporine therapy].
    Rob PM
    Fortschr Med; 1996 Apr; 114(10):125-6. PubMed ID: 8655118
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnesium deficiency after renal transplantation and cyclosporine treatment despite normal serum-magnesium detected by a modified magnesium-loading-test.
    Rob PM; Bley N; Dick K; Rohwer J; Sack K
    Transplant Proc; 1995 Dec; 27(6):3442-3. PubMed ID: 8540042
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum Magnesium and Related Factors in Long-Term Renal Transplant Recipients: An Observational Study.
    Rodrigues N; Santana A; Guerra J; Neves M; Nascimento C; Gonçalves J; da Costa AG
    Transplant Proc; 2017 May; 49(4):799-802. PubMed ID: 28457398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.
    Sabbagh F; El Tawil Z; Lecerf F; Hulin A; Maurois P; Dartevelle P; Bac P; German-Fattal M
    Transplantation; 2008 Aug; 86(3):436-44. PubMed ID: 18698248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient.
    Ko WJ; Lin FL; Wang SS; Chu SH
    J Heart Lung Transplant; 1997 Sep; 16(9):980-2. PubMed ID: 9322151
    [No Abstract]   [Full Text] [Related]  

  • 8. Update on gingival overgrowth by cyclosporine A in renal transplants.
    Ciavarella D; Guiglia R; Campisi G; Di Cosola M; Di Liberto C; Sabatucci A; Escudero N; Bascones A; Lo Muzio L
    Med Oral Patol Oral Cir Bucal; 2007 Jan; 12(1):E19-25. PubMed ID: 17195822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical safety and tolerability of microemulsion cyclosporine in stable renal transplant patients.
    Gracida C; Melchor JL
    Transplant Proc; 1996 Dec; 28(6):3379. PubMed ID: 8962318
    [No Abstract]   [Full Text] [Related]  

  • 10. [High prevalence of sebaceous hyperplasias in renal transplants].
    Pérez-España L; Prats I; Sanz A; Mayor M
    Nefrologia; 2003; 23(2):179-80. PubMed ID: 12778886
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of tolerability, safety, and efficacy of cyclosporine microemulsion in renal transplant recipients.
    Gracida C; Melchor JL; Miranda ME; Bartolano C
    Transplant Proc; 1996 Aug; 28(4):2171-3. PubMed ID: 8769191
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine not the only agent to cause Guillain-Barré-like syndrome after solid-organ transplant.
    Hunt I
    J Heart Lung Transplant; 2006 Nov; 25(11):1387. PubMed ID: 17097509
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chronic myeloid leukemia after kidney transplantation].
    Fernández-Avilés F; Ribera JM; Batlle M; Lauzurica R
    Sangre (Barc); 1997 Feb; 42(1):85-6. PubMed ID: 9229811
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cyclosporine-induced nephropathy in patients after heart transplantation -- a significant clinical problem].
    Dziewanowski K; Kurowski M; Kopeć E; Busz-Papiez B
    Kardiol Pol; 2006 May; 64(5):522-5. PubMed ID: 16752339
    [No Abstract]   [Full Text] [Related]  

  • 15. [Uricemia-lowering activity of losartan in kidney transplantation].
    Otero Glz A; Pérez Melón C; Armada E; Gayoso P
    Nefrologia; 2002; 22(2):204-5. PubMed ID: 12085424
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical study of sandimmun neoral in cadaveric renal transplantation.
    Xue W; Chen Y; Xing J; Tian P
    Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and tolerability of Sandimmun Neoral vs Sandimmun in de novo renal transplant patients after 24 months' treatment. German Neoral Study Group.
    Buchholz B; Korn A
    Transplant Proc; 1996 Aug; 28(4):2187-8. PubMed ID: 8769195
    [No Abstract]   [Full Text] [Related]  

  • 18. Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients: a case-control study.
    Copstein LA; Zelmanovitz T; Gonçalves LF; Manfro RC
    Transplant Proc; 2004 May; 36(4):882-3. PubMed ID: 15194302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal alopecia areata during systemic cyclosporine A therapy.
    Cerottini JP; Panizzon RG; de Viragh PA
    Dermatology; 1999; 198(4):415-7. PubMed ID: 10490301
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and tolerability of CyA microemulsion formulation (Sandimmun Neoral) in stable renal transplant patients after 24 months of treatment. German Neoral Study Group.
    Offermann G; Korn A
    Transplant Proc; 1996 Aug; 28(4):2204-6. PubMed ID: 8769201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.